BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3565791)

  • 21. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E
    Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease.
    Monroe P; Vlahcevic ZR; Swell L
    Gastroenterology; 1983 Oct; 85(4):820-9. PubMed ID: 6884708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I evaluation and pharmacokinetic study of pyrazine-2-diazohydroxide administered as a single bolus intravenous injection in patients with advanced solid tumors.
    Supko JG; Balcerzak SP; Kraut EH
    Cancer Res; 1993 Oct; 53(20):4843-9. PubMed ID: 8402671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphine pharmacokinetics in renal failure.
    Chauvin M; Sandouk P; Scherrmann JM; Farinotti R; Strumza P; Duvaldestin P
    Anesthesiology; 1987 Mar; 66(3):327-31. PubMed ID: 3826690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetics of whole-body water and bromide space in patients with liver cirrhosis (author's transl)].
    Schober O; Mariss P; Hehrmann R; Schmidt FW; Hundeshagen H
    Nuklearmedizin; 1979 Feb; 18(1):7-13. PubMed ID: 432111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioimmunoassay of plasma arginine-vasopressin in the cirrhotic patient. 15 patients].
    Guillemant S; Vitoux JF; Desgrez P; Saigot T; Sarrazin A
    Nouv Presse Med; 1978 Oct; 7(34):3048-9. PubMed ID: 724460
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure.
    Aitkenhead AR; Vater M; Achola K; Cooper CM; Smith G
    Br J Anaesth; 1984 Aug; 56(8):813-9. PubMed ID: 6743445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alprazolam pharmacokinetics in alcoholic liver disease.
    Juhl RP; Van Thiel DH; Dittert LW; Smith RB
    J Clin Pharmacol; 1984; 24(2-3):113-9. PubMed ID: 6143766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of controlled release morphine (MST) in patients with liver cirrhosis.
    Kotb HI; el-Kabsh MY; Emara SE; Fouad EA
    Br J Anaesth; 1997 Dec; 79(6):804-6. PubMed ID: 9496218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate-limiting diffusion processes following intrathecal administration of morphine.
    Sandouk P; Scherrmann JM; Chauvin M
    Eur J Clin Pharmacol; 1986; 30(5):575-9. PubMed ID: 3758145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine pharmacokinetics: GLC assay versus radioimmunoassay.
    Stanski DR; Paalzow L; Edlund PO
    J Pharm Sci; 1982 Mar; 71(3):314-7. PubMed ID: 7069588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pefloxacin kinetics in cirrhosis.
    Danan G; Montay G; Cunci R; Erlinger S
    Clin Pharmacol Ther; 1985 Oct; 38(4):439-42. PubMed ID: 3862496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prolonged intravenous infusion of morphine. Pharmacokinetic study].
    Tanguy M; Malledant Y; Le Verge R; Gibassier D; Saint-Marc C
    Ann Fr Anesth Reanim; 1987; 6(1):22-8. PubMed ID: 3578942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ornidazole in patients with severe liver cirrhosis.
    Taburet AM; Delion F; Attali P; Thebault JJ; Singlas E
    Clin Pharmacol Ther; 1986 Sep; 40(3):359-64. PubMed ID: 3742940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profound reduction in morphine clearance and liver blood flow in shock.
    Macnab MS; Macrae DJ; Guy E; Grant IS; Feely J
    Intensive Care Med; 1986; 12(5):366-9. PubMed ID: 3771915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of midazolam in anaesthetized cirrhotic patients.
    Trouvin JH; Farinotti R; Haberer JP; Servin F; Chauvin M; Duvaldestin P
    Br J Anaesth; 1988 Jun; 60(7):762-7. PubMed ID: 3395535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of renal function on the elimination of morphine and morphine glucuronides.
    Wolff J; Bigler D; Christensen CB; Rasmussen SN; Andersen HB; Tønnesen KH
    Eur J Clin Pharmacol; 1988; 34(4):353-7. PubMed ID: 3402521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diphenhydramine disposition in chronic liver disease.
    Meredith CG; Christian CD; Johnson RF; Madhavan SV; Schenker S
    Clin Pharmacol Ther; 1984 Apr; 35(4):474-9. PubMed ID: 6705445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphine kinetics during and after renal transplantation.
    Moore A; Sear J; Baldwin D; Allen M; Hunniset A; Bullingham R; McQuay H
    Clin Pharmacol Ther; 1984 May; 35(5):641-5. PubMed ID: 6370555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.